434 related articles for article (PubMed ID: 37860928)
1. Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer.
Wang X; Zhou L; Wang H; Chen W; Jiang L; Ming G; Wang J
Cancer Med; 2023 Nov; 12(21):20573-20589. PubMed ID: 37860928
[TBL] [Abstract][Full Text] [Related]
2. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
3. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy.
Gu X; Liu Y; Dai X; Yang YG; Zhang X
Front Immunol; 2023; 14():1137107. PubMed ID: 36926345
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be?
Zhou Q; Tao C; Yuan J; Pan F; Wang R
Biomed Pharmacother; 2023 Sep; 165():115251. PubMed ID: 37523985
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance.
Jiang T; Chen X; Ren X; Yang JM; Cheng Y
Drug Resist Updat; 2021 May; 56():100752. PubMed ID: 33765484
[TBL] [Abstract][Full Text] [Related]
7. ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.
Jiang F; Jia K; Chen Y; Ji C; Chong X; Li Z; Zhao F; Bai Y; Ge S; Gao J; Zhang X; Li J; Shen L; Zhang C
Adv Sci (Weinh); 2023 Aug; 10(24):e2300881. PubMed ID: 37341301
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Interplay Between Autophagy and Ferroptosis and Their Synergistical Roles on Manipulating Immunological Tumor Microenvironment in Squamous Cell Carcinomas.
Chen L; Niu X; Qiao X; Liu S; Ma H; Shi X; He X; Zhong M
Front Immunol; 2021; 12():739039. PubMed ID: 35185859
[TBL] [Abstract][Full Text] [Related]
9. Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer.
Zhao L; Liu Y; Zhang S; Wei L; Cheng H; Wang J; Wang J
Cell Death Dis; 2022 Apr; 13(4):378. PubMed ID: 35444235
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications.
Zhai X; Lin Y; Zhu L; Wang Y; Zhang J; Liu J; Li L; Lu X
Cytokine Growth Factor Rev; 2024 Feb; 75():101-109. PubMed ID: 37658030
[TBL] [Abstract][Full Text] [Related]
11. Exploring the landscape of drug resistance in gastrointestinal cancer immunotherapy: A review.
Yao N; Li W; Duan N; Xu G; Yu G; Qu J
Medicine (Baltimore); 2024 Jan; 103(2):e36957. PubMed ID: 38215151
[TBL] [Abstract][Full Text] [Related]
12. Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma.
Liu L; Jin H; Dong M; Tian J; Li H; Liu Q; Chen Y; Zou Z
Apoptosis; 2022 Dec; 27(11-12):946-960. PubMed ID: 36028785
[TBL] [Abstract][Full Text] [Related]
13. Association between Metabolic Reprogramming and Immune Regulation in Digestive Tract Tumors.
Liu J; Wang T; Zhang W; Huang Y; Wang X; Li Q
Oncol Res Treat; 2024; 47(6):273-286. PubMed ID: 38636467
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis in the tumor microenvironment: perspectives for immunotherapy.
Xu H; Ye D; Ren M; Zhang H; Bi F
Trends Mol Med; 2021 Sep; 27(9):856-867. PubMed ID: 34312075
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis regulates key signaling pathways in gastrointestinal tumors: Underlying mechanisms and therapeutic strategies.
Rabitha R; Shivani S; Showket Y; Sudhandiran G
World J Gastroenterol; 2023 Apr; 29(16):2433-2451. PubMed ID: 37179581
[TBL] [Abstract][Full Text] [Related]
16. Programmed Cell Death Tunes Tumor Immunity.
Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
Front Immunol; 2022; 13():847345. PubMed ID: 35432318
[TBL] [Abstract][Full Text] [Related]
17. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy.
Shi Y; Wang Y; Dong H; Niu K; Zhang W; Feng K; Yang R; Zhang Y
Apoptosis; 2023 Oct; 28(9-10):1423-1435. PubMed ID: 37369808
[TBL] [Abstract][Full Text] [Related]
19. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
[TBL] [Abstract][Full Text] [Related]
20. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
